§ Mr. Baker
To ask the Secretary of State for Health if GM crops designed to produce products or by-products with medicinal properties will be subject to regulation under the Medicines Act 1968. 
§ Ms Jowell
[holding answer 23 July 1999]: Products and by-products made from genetically modified crops which satisfied the definition of a medicinal product, as defined in Article 1 of Directive 65/65/EEC, would be subject to medicines legislation. The Medicines Act does not cover the regulation of crop cultivation. The Department of the Environment Transport and the Regions is responsible for implementing Directive 90/220 on the deliberate release of genetically modified organisms.